Given the limited number of inv(16) patient samples and the similar TIM-3 expression levels in inv(16) and t(8;21) subtypes, the following prognostic analysis focused solely on t(8;21) and non-CBF-AML patients. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.